DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, is planning to provide business and pipeline updates to the investor community at a series of conferences over the reminder of 2010. The Company will be represented by David Bupp, CEO & President, and Brent Larson, SVP & CFO, who invite you to join them at the following confirmed events:
